SCHEMBL8095056

SCHEMBL8095056

O=C(Nc1ccc(Cl)c(Cl)c1)NS(=O)(=O)C1CCCCC1.[Na]

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.54
EPHX1 P07099 2/20 0.54
KMT2A Q03164 7/20 0.50
MEN1 O00255 6/20 0.50
MAPT P10636 3/20 0.50
CA2 P00918 3/20 0.50
CA9 Q16790 3/20 0.50
NPSR1 Q6W5P4 2/20 0.50
CA4 P22748 1/20 0.50
CA5A P35218 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HTT P42858 3/20 0.49
NPC1 O15118 3/20 0.49
LMNA P02545 2/20 0.49
ADORA3 P0DMS8 1/20 0.49
CHRM1 P11229 1/20 0.49
SLC6A2 P23975 1/20 0.49
PDE4A P27815 1/20 0.49
ADRA1A P35348 1/20 0.49
OPRM1 P35372 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8095054 0.97 EPHX2 (0.54) EPHX2EPHX1KMT2AMEN1MAPT
SCHEMBL8089968 0.97 EPHX2 (0.57) EPHX2EPHX1KMT2AMEN1MAPT
SCHEMBL8095024 0.83 RAB9A (0.60) EPHX1KMT2AMEN1MAPTCA2
SCHEMBL8083387 0.82 RAB9A (0.57) EPHX1KMT2AMEN1CA2CA9
SCHEMBL8089942 0.81 RAB9A (0.56) EPHX1KMT2AMEN1CA2CA9
SCHEMBL6466718 0.77 EPHX1 (0.58) EPHX2EPHX1KMT2AMEN1MAPT
SCHEMBL6465976 0.77 MEN1 (0.49) EPHX2EPHX1KMT2AMEN1CA2
SCHEMBL8091213 0.76 RAB9A (0.57) EPHX1KMT2AMEN1MAPTCA2
SCHEMBL8091184 0.76 RAB9A (0.57) EPHX1KMT2AMEN1CA2CA9
SCHEMBL19505872 0.76 ACP1 (0.57) EPHX2EPHX1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147115-A SULFONYLUREIDO-4-HALOBENZENE DERIVATIVES; ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 2000-11-14 US disclosed
EP-0467621-B1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them LILLY CO ELI (US) 1994-06-15 EP disclosed
US-5216026-A Administering to the mammal N-1-butanesulfonamide derivatives and salts ELI LILLY AND COMPANY (US) 1993-06-01 US disclosed
EP-0467621-A1 N-phenyl-N'-alkylsulfonylureas, process for their preparation and antitumor compositions containing them ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed